Page 2 - Martin Felices News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BRISBANE, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) GT Biopharma, Inc. (the “Company” or “GTB”) (NASDAQ: GTBP), a clinical stage immuno-oncology company.

United statesCorey davisMartin felicesPippa kennedyShee kwan phungExchange commissionSociety for immunotherapy of cancerGlobe newswire gt biopharma incUniversity of minnesotaGt biopharma incAnnual meetingPoster hallTri specific killer engagerRelations contactsNasdaq gtbpGt biopharma